Stevens M - Search Results

1

Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.

Van Neck T, Pannecouque C, Vanstreels E, Stevens M, Dehaen W, Daelemans D. Van Neck T, et al. Among authors: stevens m. Bioorg Med Chem. 2008 Nov 1;16(21):9487-97. doi: 10.1016/j.bmc.2008.09.051. Epub 2008 Sep 20. Bioorg Med Chem. 2008. PMID: 18835718

2

Structure-activity relationship study on anti-HIV 6-desfluoroquinolones.

Tabarrini O, Massari S, Daelemans D, Stevens M, Manfroni G, Sabatini S, Balzarini J, Cecchetti V, Pannecouque C, Fravolini A. Tabarrini O, et al. Among authors: stevens m. J Med Chem. 2008 Sep 11;51(17):5454-8. doi: 10.1021/jm701585h. Epub 2008 Aug 19. J Med Chem. 2008. PMID: 18710207

3

Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives.

Stevens M, Pannecouque C, De Clercq E, Balzarini J. Stevens M, et al. Antimicrob Agents Chemother. 2003 Sep;47(9):2951-7. doi: 10.1128/AAC.47.9.2951-2957.2003. Antimicrob Agents Chemother. 2003. PMID: 12937000 Free PMC article.

4

Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action.

Stevens M, Pannecouque C, De Clercq E, Balzarini J. Stevens M, et al. Antimicrob Agents Chemother. 2003 Oct;47(10):3109-16. doi: 10.1128/AAC.47.10.3109-3116.2003. Antimicrob Agents Chemother. 2003. PMID: 14506017 Free PMC article.

5

Structure modifications of 6-aminoquinolones with potent anti-HIV activity.

Tabarrini O, Stevens M, Cecchetti V, Sabatini S, Dell'Uomo M, Manfroni G, Palumbo M, Pannecouque C, De Clercq E, Fravolini A. Tabarrini O, et al. Among authors: stevens m. J Med Chem. 2004 Oct 21;47(22):5567-78. doi: 10.1021/jm049721p. J Med Chem. 2004. PMID: 15481992

6

Pyridine N-oxide derivatives inhibit viral transactivation by interfering with NF-kappaB binding.

Stevens M, Pannecouque C, De Clercq E, Balzarini J. Stevens M, et al. Biochem Pharmacol. 2006 Apr 14;71(8):1122-35. doi: 10.1016/j.bcp.2005.12.025. Epub 2006 Jan 24. Biochem Pharmacol. 2006. PMID: 16438940

7

Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives.

Stevens M, Balzarini J, Lagoja IM, Noppen B, François K, Van Aerschot A, Herdewijn P, De Clercq E, Pannecouque C. Stevens M, et al. Virology. 2007 Aug 15;365(1):220-37. doi: 10.1016/j.virol.2007.03.036. Epub 2007 Apr 24. Virology. 2007. PMID: 17459445 Free article.

8

Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.

Stevens M, Pollicita M, Pannecouque C, Verbeken E, Tabarrini O, Cecchetti V, Aquaro S, Perno CF, Fravolini A, De Clercq E, Schols D, Balzarini J. Stevens M, et al. Antimicrob Agents Chemother. 2007 Apr;51(4):1407-13. doi: 10.1128/AAC.01251-06. Epub 2007 Jan 22. Antimicrob Agents Chemother. 2007. PMID: 17242146 Free PMC article.

9

Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.

Stevens M, Balzarini J, Tabarrini O, Andrei G, Snoeck R, Cecchetti V, Fravolini A, De Clercq E, Pannecouque C. Stevens M, et al. J Antimicrob Chemother. 2005 Nov;56(5):847-55. doi: 10.1093/jac/dki328. Epub 2005 Sep 8. J Antimicrob Chemother. 2005. PMID: 16150861

10

Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action.

Balzarini J, Stevens M, De Clercq E, Schols D, Pannecouque C. Balzarini J, et al. Among authors: stevens m. J Antimicrob Chemother. 2005 Feb;55(2):135-8. doi: 10.1093/jac/dkh530. Epub 2005 Jan 13. J Antimicrob Chemother. 2005. PMID: 15650002 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,005 results

Search Page

Filters